Trokide Vertical-Haler
Trokide Vertical-Haler® is a dry powder inhaler (DPI) which is therapeutically equivalent to Spiriva® HandiHaler® for formulation and device characteristics.1,2
Trokide® (tiotropium bromide) indications1
Trokide Vertical-Haler® is indicated as a maintenance bronchodilator treatment to relieve symptoms of patients with chronic obstructive pulmonary disease (COPD).
Instructions for reporting Adverse Events can be found in the footer of this page. Prescribing information is available here.
Unlock Savings With Trokide®
Save up to 71% annually for the NHS vs other tiotropium bromide inhalers.3
*Savings based on indicative NHS list prices.3
Equivalence to Spiriva® HandiHaler®
Trokide Vertical-Haler® is equivalent to Spiriva® HandiHaler® in terms of:2
- active ingredient
- delivered dose per actuation
- inhaling technique
- therapeutic effect and device characteristics
Demonstration devices are also available

Device Characteristics
1. Cap | 2. Mouthpiece | 3. Base
4. Push button | 5. Capsule chamber/nest
Implementation Support
We’re here to support you all the way through the implementation process, with formulary support documents, cost calculators for your area, letters as well as materials for both healthcare professionals and patients.
Formulary Review Process:
-
- Formulary application support document
Request document - Tailored cost-savings report detailing savings for your area
Request report - Price & stock commitment letter
- Pharmacy letter – introduction to formulary
- Formulary application support document
For Healthcare Professionals:
- Product information leaflets
- Demonstration devices for training
Request demo devices
For Patients
- Device demonstration video
- Leaflet with instructions for use
- Letter to explain change in inhaler
- Website
Visit patient website
References
- Trokide® Prescribing Information. Accessed: November 2026.
- STADA UK Ltd. 2024. Data on File. Trokide Pharmaceutical Development.
- BNF. Tiotropium: Medicinal forms. Accessed: November 2026.
- NHS England. 2021. Delivering a ‘Net Zero’ National Health Service. Accessed: November 2026.
- Teva UK Ltd. 2019. Summary of Product Characteristics. Braltus Tiotropium (Braltus) 10mcg inhalation powder. Accessed: November 2026.